When Blood Transfusion Is Not an Option: Yale Neuro-ICU Successfully Administers Transfusion Replacement Therapy
The Yale New Haven neuro-ICU has successfully administered a transfusion replacement therapy, which benefits patients with aneurysmal subarachnoid hemorrhage (SAH), as well as those with severe anemia from blood loss and critical illness.
$3.59M NIMH Grant Awarded to Serena Spudich, MD
A new, five-year, $3.59M grant from the National Institute of Mental Health (NIMH) was awarded to Principal Investigator Serena Spudich, MD, Gilbert Glaser Professor of Neurology at Yale, along with co-PI, Joshua Cyktor, PhD, of the University of Pittsburgh.
AAN 2021 Virtual Annual Meeting: Highlights
Each year, the American Academy of Neurology (AAN) hosts a meeting wherein neurologists nationwide convene to present on their latest research findings and to learn from their peers. The following members of Yale Neurology presented abstracts at the 2021 virtual annual meeting:
PATHS helps students from underrepresented backgrounds realize med school dreams
Nelson Perez Catalan discovered he was interested in pursuing science while working at a student job at the University of Oregon cleaning glass in the labs. He found himself drawn to research around the brain, and thought about pursuing an MD/PhD, but there was no medical school at his university and as a transplant from Chile, he says much of the U.S. college process was mystifying to him. Then he learned about PATHS, or Program to Advance Training in Health and Sciences at Yale School of Medicine.
CELLO Study to Explore Early Treatment of Multiple Sclerosis
Yale University announced today the initiation of a multicenter study aimed at treating early stage multiple sclerosis (MS). Supported by and in collaboration with Genentech, a member of the Roche Group, the study, known as “CELLO,” will investigate whether short-term treatment with ocrelizumab in patients with MRI lesions consistent with early MS without clinical disease—known as radiologic isolated syndrome—prevents the onset of symptoms.
National Multiple Sclerosis Society Postdoctoral Fellowship Awarded to Dr. Soumya Yandamuri
Postdoctoral Fellow Dr. Soumya Yandamuri, MSE, PhD has been awarded the National Multiple Sclerosis Society Postdoctoral Fellowship. The grant, “Isolation and characterization of myelin oligodendrocyte glycoprotein monoclonal antibodies,” funds three years and will begin in July 2021.
Dr. Guido Falcone Selected for Michael S. Pessin Stroke Leadership Prize
The American Academy of Neurology has awarded Assistant Professor of Neurology Dr. Guido Falcone, MD, ScD, MPH with the 2021 Michael S. Pessin Stroke Leadership Prize in recognition of his outstanding achievements in stroke research.
Yale Neurologists Identify Consistent Neuroinflammatory Response in ICH Patients
According to a recent study published in "Science Immunology," A team of researchers from Yale and MIT partnernered with a large clinical trial of minimally-invasive surgery to tackle defining the human neuroinflammatory response in living patients suffering from intracerebral hemorrhage.
Dr. David Hafler Elected to the Association of American Physicians
David Hafler, MD, FANA, William S. and Lois Stiles Edgerly Professor of Neurology and Professor of Immunobiology; Chair, Department of Neurology; Neurologist-in-Chief, Yale New Haven Hospital has been elected to the Association of American Physicians (AAP).
Dr. Jeremy Moeller Selected for AAN 2021 Residency-Fellowship Program Director Recognition Award
Dr. Jeremy Moeller, MD, MSc, FRCP(C), Associate Professor, Associate Vice-Chair of Education, and Neurology Residency Program Director, has been selected as one of the recipients of the American Academy of Neurology (AAN) 2021 Residency-Fellowship Program Director Recognition Award.
R21 NINDS Grant Awarded to Dr. Lauren Sansing
An R21 grant from the National Institute of Neurological Disorders and Stroke(NINDS) has been awarded to Principal Investigator Dr. Lauren Sansing, MD, MS, FAHA, FANA. The R21NS108060 grant is entitled “Manipulation of metabolic pathways to enhance human macrophage phenotypes after ICH.”
ACTG names second new award for Kevin Robertson
Serena Spudich, MD, professor of neurology and chief of Neurological Infections & Global Neurology at Yale University, is the first recipient of this award named in honor of beloved UNC neurology professor Kevin Robertson.Source: UNC Health and UNC School of Medicine